September 20, 2014 8:05 PM ET

Pharmaceuticals

Company Overview of Endo Pharmaceuticals Solutions Inc.

Company Overview

Endo Pharmaceuticals Solutions Inc. develops products to treat conditions in urology and endocrinology in the United States. The company’s approved products consist SANCTURA, a muscarinic receptor antagonist, and SANCTURA XR for the treatment of overactive bladder that are co-promoted with its partner Allergan, Inc.; VANTAS for treating advanced prostate cancer; SUPPRELIN LA for central precocious puberty; and DELATESTRYL for the treatment of hypogonadism. Its urology and endocrinology development portfolio contains multiple compounds, which comprise NEBIDO for hypogonadism; VALSTAR for bladder cancer; PRO 2000 for the prevention of infection by HIV and other sexually-transmitted diseases; t...

100 Endo Boulevard

Chadds Ford, PA 19317

United States

Founded in 1988

246 Employees

Phone:

610-558-9800

Fax:

484-840-4287

Key Executives for Endo Pharmaceuticals Solutions Inc.

Chief Legal Officer
Age: 45
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Ariel Pharmaceuticals, Inc. United States
UAS Laboratories, Inc. United States
KI NutriCare, Inc. United States
D.P. Marketing, Inc. United States
Santarus, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Endo Pharmaceuticals Solutions Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.